Drugs / Tamoxifen Pill
last change Apr 2023 re-read 2 minutes ago

Tamoxifen Pill

Developed for
estrogen-receptor positive breast cancer
Investigated by
University of Virginia

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04038489 Oct 2019 → Apr 2023 estrogen-receptor positive breast cancer University of Virginia Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tamoxifen Pill ClinicalTrials.gov intervention name — accepted as the source's own label NCT04038489